Quidel

News Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Date Title
08/30/18Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument from Finger-Stick Whole Blood Specimens
08/07/18Quidel Reports Second Quarter 2018 Financial Results
07/17/18Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018
07/16/18Quidel Receives FDA Clearance for Solana® Bordetella Complete® Molecular Diagnostic Assay for the Detection of Pertussis (Whooping Cough), Parapertussis Infections
06/05/18Quidel to Present at William Blair 38th Annual Growth Stock Conference
05/31/18Quidel Announces Private Exchange Transactions
05/15/18Quidel to Present at UBS Global Healthcare Conference
05/08/18Quidel Reports First Quarter 2018 Financial Results
04/23/18Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018
03/27/18Quidel to Host 2018 Analyst and Investor Day in Chicago
03/08/18Quidel Announces Private Exchange Transactions
03/05/18Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument
02/26/18Quidel to Present at Upcoming Conferences
02/21/18Quidel Reports Fourth Quarter and Full Year 2017 Financial Results
02/13/18Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements
02/07/18Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018
01/05/18Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million